-
Product Insights
Contrast Agents Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Contrast Agents Pipeline Market Report Overview The Contrast Agents pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials. Key Segments · Positron Emitting Tomography Contrast Agents · Magnetic Resonance Imaging (MRI) Contrast Agents · Gadolinium-based MRI Contrast Agents...
-
Product Insights
Switzerland Sparkling Wine market dynamics
Empower your strategies with our Switzerland Sparkling Wine market dynamics report and make more profitable business decisions. Consumers' preferences for wines and spirits are most heavily influenced by novel flavors, premium ingredients, product prices, and packaging. However, manufacturers continue to launch and sell products based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Wines and spirits manufacturers can benefit from the unique intelligence provided by the GlobalData Consumer Intelligence platform, covering more than 2 million products...
-
Company Profile
Cellectar Biosciences Inc – Company Profile
Cellectar Biosciences Inc (Cellectar), is a biopharmaceutical company that discovers, develops and commercializes drugs for treatment of cancer. The company’s proprietary technology, phospholipid drug conjugates (PDC) delivery platform develops PDCs for the treatment and diagnosis of cancer. Its lead product includes CLR 131, is a small-molecule PDC, in Phase II clinical trials for the treatment of relapse or refractory multiple myeloma and B-cell lymphomas. The company is also evaluating CLR 131 in Phase I clinical trials for treatment of Pediatric...
Add to Basket -
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – CLR-325
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry CLR-325 Drug Details CLR-325 is under development for the treatment of chronic stable heart...
-
Product Insights
Net Present Value Model: Iopofosine i-131
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Iopofosine i-131 Drug Details Iopofosine I-131...
-
Product Insights
Alpha Synuclein (Non A Beta Component Of AD Amyloid or Non A4 Component Of Amyloid Precursor or NACP or SNCA) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Alpha Synuclein Drugs Development Market Report Overview Alpha-synuclein (Non A Beta Component Of AD Amyloid or Non A4 Component Of Amyloid Precursor or NACP or SNCA) is a protein normally found in cells all over the body. It is one of the key players in Parkinson’s. In Parkinson’s, it forms clumps inside the specific nerve cells that produce the chemical dopamine. It is involved in the regulation of dopamine release and transport. It induces fibrillization of microtubule-associated protein tau. It...
-
Product Insights
Ewing Sarcoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Ewing's sarcoma is a primary bone cancer that affects mainly children and adolescents. Ewing's sarcoma can occur any time during childhood and young adulthood, but usually develops during puberty, when bones are growing rapidly. The Ewing Sarcoma pipeline drugs market research report provides comprehensive information on the therapeutics under development for Ewing Sarcoma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological...
-
Sector Analysis
Opportunities in the Eastern European Wine Sector to 2025
The global wine sector was valued at US$313,500.2 million in 2020. During the forecast period of 2020-2025, it is set to grow at a CAGR of 6.75% to reach US$434,500.8 million by 2025. Eastern Europe ranked second lowest in the global wine market in 2020, with a value share of 9.9%. It recorded value and volume sales of US$31,069 million and 3,234.2 million liters, respectively, in 2020. During 2020-2025, the region is forecast to grow at value and volume CAGRs...
-
Product Insights
Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1, 2017" provides an overview of Chronic Lymphocytic Leukemia (CLL) clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Lymphocytic Leukemia (CLL). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...